CMS ended the VBID Hospice Benefit Component on December 31, 2024, so participating plans could not offer hospice as an MA benefit through that component in 2025
However, it is reasonable to consider what is known from related drug classes
AOD-9604 vs Tesamorelin at a Glance AOD-9604 Type GH fragment (amino acids 176 to 191) Tesamorelin Type GHRH analog (stabilized) AOD-9604 Mechanism Acts on fat cells directly
Semaglutidea medication originally designed for type 2 diabetes that is now making headlines for its remarkable effectiveness in weight loss
At a glance Drug class / retatrutide is an investigational GIP, GLP-1, and glucagon triple receptor agonist Interaction type / no known direct pharmacokinetic interaction with vitamin D Vitamin D deficiency prevalence / up to 35% of U.S
Remarkably, half of the participants managed to shed 15% of their body weight, and nearly one-third lost 20%